TrueBinding (former Immutics) Revenue and Competitors
Estimated Revenue & Valuation
- TrueBinding (former Immutics)'s estimated annual revenue is currently $15.7M per year.
- TrueBinding (former Immutics)'s estimated revenue per employee is $155,000
Employee Data
- TrueBinding (former Immutics) has 101 Employees.
- TrueBinding (former Immutics) grew their employee count by -32% last year.
TrueBinding (former Immutics)'s People
Name | Title | Email/Phone |
---|---|---|
1 | Associate Director Manufacturing | Reveal Email/Phone |
2 | Senior Scientist Bioanalytics | Reveal Email/Phone |
TrueBinding (former Immutics) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.3M | 21 | 31% | N/A | N/A |
What Is TrueBinding (former Immutics)?
Researching and developing first-in-class monoclonal antibody drugs to treat tumor, fibrotic diseases, metabolic diseases, autoimmune diseases and neurologic diseases.
keywords:N/AN/A
Total Funding
101
Number of Employees
$15.7M
Revenue (est)
-32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.4M | 106 | 13% | N/A |
#2 | $15M | 107 | -19% | $128M |
#3 | $23.1M | 110 | 120% | N/A |
#4 | $7.5M | 110 | 4% | N/A |
#5 | $17.5M | 113 | -3% | N/A |